GPC5 (N-term), 56-84 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-GPC5 (N-term), 56-84 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityGPC5 (N-term), 56-84
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.5
ApplicationsWestern Blot (WB), ELISA (EIA), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis GPC5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 56-84 amino acids from the N-terminal region of human GPC5. Cell surface heparan sulfate proteoglycans are composed ofa membrane-associated protein core substituted with a variablenumber of heparan sulfate chains. Members of the glypican-relatedintegral membrane proteoglycan family (GRIPS) contain a coreprotein anchored to the cytoplasmic membrane via a glycosylphosphatidylinositol linkage. These proteins may play a role inthe control of cell division and growth regulation. [provided byRefSeq].
Immunogenn/a
Other Names[Glypican-5; Secreted glypican-5; GPC5]
Gene, Accession #[GPC5], Gene ID: 2262, NCBI: NP_004457.1, UniProt: P78333
Catalog #MBS9208056
Price$165, $370
Order / More InfoGPC5 (N-term), 56-84 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesLorentzen, A.R., et al. J. Neuroimmunol. 226 (1-2), 194-197 (2010) : Landi, M.T., et al. Lancet Oncol. 11(8):714-716(2010) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Li, Y., et al. Lancet Oncol. 11(4):321-330(2010) Arking, D.E., et al. PLoS ONE 5 (3), E9879 (2010) :
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.